Project Will Evolve Data Sharing Paradigm with the Goal of Rapidly Bringing Data from ongoing Clinical Trials to the Research Community BOSTON, MANHATTAN BEACH, CALIF. – Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced that it has been selected by the Pancreatic Cancer Action Network (PanCAN) to build a customized, integrated health data platform […]
Auckland, NZ – Boston-based antibody discovery services company Abveris has partnered with Biomatters to incorporate the Geneious Biologics data analysis platform into their antibody discovery workflow. In collaboration, a new Single Clone Antibody Annotator pipeline has been developed. With a rapidly growing customer base and a wide range of antibody discovery services, Abveris plans to […]
The highly requested and long-awaited interaction search is finally here! Given the great amount of structural data we have at hand, the ability to mine ligand-protein complexes based on the interactions they create was a missing piece in our analytics toolbox. The scientific applications of this new feature are numerous: Idea generation: finding new chemical […]
The Seven Bridges Bioinformatics Ecosystem Supports the Critical Turnaround Times for the CareDx AlloSure® 3.0 Workflow BOSTON—Seven Bridges, the industry-leading bioinformatics ecosystem provider, announced today a new partnership with CareDx, Inc. (Nasdaq: CDNA) supporting the CareDx AlloSure 3.0 workflow. CareDx is a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value […]
BOSTON—Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the successful completion of independent examinations for SOC 2 Type 2, SOC 3 and HIPAA. The examinations were conducted by independent service auditor Schellman and Company, LLC. These additions to the Seven Bridges compliance portfolio complement the company’s existing ISO 27001, ISO 27017, ISO 27018 and […]
Leading Japanese solution provider for drug discovery extends use of automated screening data analysis platform to expand their offering of drug discovery screening with innovative screening technologies Tokyo, Japan – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that leading Japanese solution provider in the drug discovery space Axcelead Drug […]
Cambridge, UK – Genestack Ltd. today announced that its flagship multi-omics data catalogue, curation and integrative search product, Omics Data Manager (ODM), has been licensed and implemented by AstraZeneca. Genestack’s ODM is an enabling technology providing a central hub for organising and querying multi-omics data from multiple sites, including transcriptomics and proteomics. Curation tools, such as ODM, will enable AstraZeneca […]
• Multiple studies presented in virtual 2020 ASCO Annual Meeting highlight the impact of QIAGEN’s Sample to Insight portfolio on improving knowledge about cancer and improving patient outcomes • QCI Interpret One combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients • QIAseq Pan-cancer Multimodal […]
New Genedata Screener Release Features Advanced Assay Registration and Decision Support for Biopharma R&D Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Screener® 17.0, the latest version of its enterprise software for the automated analysis, visualization, and management of screening data from all […]
Simulations Plus today announced that it has received a new Grant Award from the FDA to enhance the ocular (OCAT) model in its GastroPlus software. Novel PBPK/PD modeling strategies for ophthalmic drug products will inform regulatory decision-making Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
